TERF2 and breast neoplasm: According to this, TRF2 expression was higher in breast tumors negative for estrogen, progesterone, and HER2 receptors (Triple Negative), characterized by the most aggressive clinical course, early relapse and poor outcome [42] (Supplementary Fig. 9B).